C
19.71
-0.43 (-2.14%)
| Previous Close | 20.14 |
| Open | 20.04 |
| Volume | 1,003,331 |
| Avg. Volume (3M) | 1,588,093 |
| Market Cap | 4,719,953,408 |
| Price / Sales | 8.10 |
| Price / Book | 10.05 |
| 52 Weeks Range | |
| Earnings Date | 14 May 2025 |
| Profit Margin | -46.34% |
| Operating Margin (TTM) | 11.41% |
| Diluted EPS (TTM) | -0.920 |
| Quarterly Revenue Growth (YOY) | 20.10% |
| Total Debt/Equity (MRQ) | 2.92% |
| Current Ratio (MRQ) | 1.82 |
| Operating Cash Flow (TTM) | 143.01 M |
| Levered Free Cash Flow (TTM) | 112.16 M |
| Return on Assets (TTM) | 6.05% |
| Return on Equity (TTM) | -115.35% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Software - Infrastructure (US) | Mixed | Mixed |
| Software - Infrastructure (Global) | Mixed | Mixed | |
| Stock | Cellebrite DI Ltd. | Bearish | Bullish |
AIStockmoo Score
0.8
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.75 |
|
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker. |
|
| Sector | Technology |
| Industry | Software - Infrastructure |
| Investment Style | Mid Growth |
| % Held by Insiders | 45.54% |
| % Held by Institutions | 47.76% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Crescent Park Management, L.P. | 31 Dec 2024 | 1,862,482 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 25.00 (JP Morgan, 26.84%) | Buy |
| Median | 24.50 (24.30%) | |
| Low | 24.00 (Needham, 21.77%) | Buy |
| Average | 24.50 (24.30%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 18.19 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Needham | 06 Jun 2025 | 24.00 (21.77%) | Buy | 16.53 |
| 14 May 2025 | 24.00 (21.77%) | Buy | 17.81 | |
| JP Morgan | 12 May 2025 | 25.00 (26.84%) | Buy | 19.85 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 24 Jun 2025 | Announcement | Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC) |
| 05 Jun 2025 | Announcement | Cellebrite to Acquire Corellium |
| 20 May 2025 | Announcement | Cellebrite Announces Participation in Upcoming Investor Conferences |
| 14 May 2025 | Announcement | Cellebrite Announces First-Quarter 2025 Results |
| 06 May 2025 | Announcement | Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations |
| 10 Apr 2025 | Announcement | Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |